We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

International Conference on Blood Disorders and Haematology 2017

Haematology, immunohaematology, hematopathology, bone marrow transplant

“International Conference on Blood Disorders and Haematology 2017” organized by Clyto Access during 21 - 22 September 2017 in San Francisco, USA. The Conference is intended to providing an international platform for the exchange of knowledge on vast area of Blood Disorders and Haematology. Blood cancer incidences, has high unmet medical necessities and demand for better therapeutics, which is considered as a some major factors behind growth of US blood cancer market segment. US Food and Drug Administration (USFDA) has taken initiatives to support the growth of cancer drugs market by providing pre-market approval to the drugs, which are in the clinical phase, thus, accelerating the clinical development. Several innovative therapeutics are at different stages of clinical trials which would be introduced in coming years.

Haematology conference 2017 is providing an international platform to discuss about the screening of novel target-based drug discovery in Haematological malignancy, enrichment of Haematopoietic stem cells function in blood disorders

to discuss new therapeutic strategy for the treatment of Chronic Myelogenous Leukemia (CML), MyeloFibrosis (MF) and Acute Lymphoblastic Leukemia    (ALL).
The conference is inviting participants to discuss on Molecular alterations in bone marrow mesenchymal stromal cells in blood disorders and    characterisation of specific Biomarkers in blood disorders.
Haematology conference 2017 is a platform to share knowledge and research work on leukemias of prenatal origin and the specific diagnostic testing   methods available in laboratories.
Also, the significant discussion on Chimeric antigen receptor (CAR) immunotherapy, TKI- based therapy and clinical manifestations in blood disorders.




21 Sep 2017 @ 12:00 am

22 Sep 2017 @ 12:01 am

Duration: 1 days


San Francisco

San Francisco

94101 San Francisco

United States

Organised by

Clyto Access (deactivated)

Recent Publications in Health

Recent Videos in Health

Recent News in Health

#EU2018BG finishes the week on a healthy note as the EU ministers in #EPSCO adopt conclusions on the #healthy child… https://t.co/ckAD7pMUP7

@EU_Health - 22 Jun 2018 14:08

@Food_EU @Act4AnimalsEU https://t.co/QLO8tPO21i

@Food_EU - 22 Jun 2018 14:06

Today #Serbia

@WHO_Europe - 22 Jun 2018 13:38

Recent Speakers in Health